Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2017-01-04 | Forward | 2:1 |
| 2015-07-01 | Forward | 553:500 |
| 1998-05-26 | Reverse | 1:2 |
Integra LifeSciences develops and markets surgical implants, instruments, and regenerative products for neurosurgery, reconstruction, and general surgery worldwide through direct sales and distribution channels.

Integra's advanced ultrasonic surgical system, FDA-cleared in November 2025 for cardiac surgeries, enables precise tissue fragmentation, emulsification, and aspiration, showcasing its innovative focus in complex surgical procedures.
| Icon | PRODUCT | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|---|
![]() | Codman Specialty Surgical | $280.66M | $303.96M ▲ | $292.58M ▼ | $323.31M ▲ |
![]() | Tissue Technologies | $101.99M | $111.65M ▲ | $109.48M ▼ | $111.62M ▲ |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | UNITED STATES | $295.85M | $320.37M ▲ | $289.38M ▼ | $307.1M ▲ |
![]() | Asia Pacific | $42.68M | $53.73M ▲ | $45.21M ▼ | $48.7M ▲ |
![]() | Europe | $42.89M | $41.85M ▼ | $39.96M ▼ | $42.57M ▲ |
![]() | Rest of the World | $20.64M | $18.96M ▼ | $17.36M ▼ | $20.39M ▲ |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
BFLY | $8.43 | COMPARE |
FTRE | $18.81 | COMPARE |
SEPN | $38.91 | COMPARE |
BCAX | $23.43 | COMPARE |
TNDM | $21.43 | COMPARE |
MRVI | $7.68 | COMPARE |
INMD | $14.85 | COMPARE |
PACB | $1.40 | COMPARE |